Top Banner
Business Time Managers Worksh op at Unit IV; Jul./ Aug. 201 1 1 Quality Assurance, A Systemic Approach for Effective Compliance. Hemanth Panasa DGM – QA (Unit IV)
73
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1

Quality Assurance,

A Systemic Approach for Effective Compliance.

Hemanth PanasaDGM – QA (Unit IV)

Page 2: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

22

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 3: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

33

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 4: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

44

Quality……Means to Public

Efficient/ Effective / Above average performance Flawless / nearly flawless The best of what you get Something we / I can depend on Some thing that will last Good workmanship Lives up to promise Tried and true / good reputation Really listening / responding / caring/ respecting Better than other Reliable/long lasting/ standard / better

Page 5: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

55

Quality……defined by ISO

The totality of features and characteristics of a product or service that bears on it the ability to satisfy stated or implied need.

Quality is…

“TO COMPLY WITH SPECIFICATIONS”

Page 6: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

66

GMPs…Good Manufacturing Practices (GMPs) are regulations (Law) that describe the methods, equipment, facilities and controls required for producing drugs.

To ensures that a drug...

• Is SAFE

• Is correctly IDENTIFIED

• Is of the right STRENGHT

• Has the PURITY it claims

• Has the overall QUALITY it claims

Page 7: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

77

GMPs…

The language of GMPs are sometimes very broad, with terms such as “adequate”, without providing details as to what is specifically required.

GMPs have evolved over time and are still evolving. As the industry adopts these improvements, they become the current industry standard.

Judges in court decide their cases frequently based on the interpretation of regulations relying both on the intent of the regulations and the current common industry practices in meeting the GMP requirements.

Page 8: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

88

CGMPs…The regulations are called ‘Current Good

Manufacturing Practices’…

…'Current' is to emphasize that the expectations are ‘Dynamic'.

The terms Current Good Manufacturing Practices (CGMPs) and Good Manufacturing Practices (GMPs)

are interchangeable.

Page 9: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

99

Origin of GMP…

Birth to GMP (First written GMP : (First written GMP :

USA, 1963)USA, 1963)

Concept of quality: Segregation between

good and bad

Concept of quality: Testing of finished

products

Lead to more failures and less consistent

quality product

Generation of need of quality building in the

product (QA/ QBD)(QA/ QBD)

Page 10: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1010

US

Japan

UK

India

Across the World…

Europe

Brazil S

A

Page 11: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1111

Regulatory Agencies…

USFDA – The USA MHRA – The UK MCC – South Africa TGA – Australia ANVISA – Brazil CDSCO – India

WHO EMEA

ICH PDA PIC/S ISPE

Page 12: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1212

Requirements of GMPs…Requirements of GMPs…At high level, GMPs of various nations are very similar. Most require things like,

Equipment and facilities being properly designed, maintained and cleaned.

Standard Operating procedures (SOPs) be written and approved.

An independent quality unit (Quality Assurance/ Control). Well trained personnel and management. Validated process/ practices.

Page 13: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1313

10 Commandments of 10 Commandments of GMP…GMP…

Principle # 1Writing detailed step-by-step procedures (SOPs) that provide a roadmap for controlled and consistent performance.

Principle # 2Carefully following written procedures to prevent contamination, mix-ups and errors.

Principle # 3 Promptly and accurately documenting work for compliance and

traceability.

Page 14: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1414

Principle # 4Proving that systems do what they are designed to do by validating work.

Principle # 5Integrating productivity, product quality, and employee safety into the design and construction of facilities and equipment.

Principle # 6Properly maintaining facilities and equipment.

Principle # 7Clearly defining, developing and demonstrating job competence.

10 Commandments of 10 Commandments of GMP…GMP…

Page 15: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1515

Principle # 8Protecting products against contamination by making cleanliness a daily habit.

Principle # 9Building quality into products by systematically controlling our components and product related processes such as manufacturing, packaging and labeling, testing, distribution, and marketing.

Principle # 10Conducting planned and periodic audits for compliance and performance.

10 Commandments of 10 Commandments of GMP…GMP…

Page 16: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1616

CGMPs Exist…To protect patients from dangerous, adulterated or misbranded products.

Adulterated product: Product that has not been manufactured according to CGMP’s, even it meets all specifications.

Misbranded product: Not labeled properly or making a false claim.

GMPs describes What to do, Not How to do.

Page 17: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1717

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 18: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1818

Quality System…Quality System…

System is a network of interdependent components that work together to try and accomplish aim of the system.

Quality System is a network, by which an organization manages its quality aspects in a systematic and organized manner .

It provides a framework/ procedures for planning, implementation and assessment of it’s aim (i.e. quality) of a product/ service of an organization.

It can also describe the methodology on how to achieve compliance to regulations. Hence, GMPs are part of the Quality System.

Page 19: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

1919

Quality System…Quality System…Quality System ensures that, products are consistently produced and controlled to the standards appropriate to their intended use.

Unlike buildings and equipments, quality systems are relative and indicator of compliance to GMPs.

Hence, quality system is the number one issue for regulatory inspectors, who will look how the Quality is Systematically addressed through out the company.

Implementation of robust Pharmaceutical Quality System is a key to comply with CGMPs

Page 20: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2020

Pharma. Quality System…Pharma. Quality System…International Conference on Harmonization (ICH), which is a consortium of US, EU and Japan with participation of Regulatory and Industry, released a guidance (ICH Q10) on Pharmaceutical Quality System (PQS).

Implementation of PQS should achieve three main objectives: Achieve Product Realization. Establish and Maintain a state of control. Facilitate Continual Improvement

Page 21: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2121

Pharma. Quality System…Pharma. Quality System…

Page 22: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2222

Pharma. Quality System…Pharma. Quality System…

The PQS is based on the concepts of Quality by Design (QbD). Implementation (developing a new system or modifying an existing one) of PQS should consider; Scope of the system to various stages of life cycle, i.e.

Pharmaceutical DevelopmentTechnology Transfer Commercial ManufactureProduct Discontinuation

The size and complexity of organization, i.e. across the site and/ or multiple sites/ countries etc.

Page 23: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2323

Knowledge Management:Knowledge management is a systematic approach to acquiring, analyzing, storing and disseminating information related to products, manufacturing processes and components.

Sources of knowledge include, but are not limited to: Prior knowledge (public domain or internally documented). Pharmaceutical development studies. Technology transfer activities. Process validation studies over the product lifecycle. Manufacturing experience. Innovation, Continual improvement and Change

management activities.

Enablers of PQS…Enablers of PQS…

Page 24: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2424

Quality Risk Management: Quality Risk Management (QRM) is integral to an effective pharmaceutical quality system. It can provide a proactive approach to identifying, scientifically evaluating and controlling potential risks to quality.

It facilitates continual improvement of process performance and product quality throughout the product lifecycle.

ICH Q9 provides principles and examples of tools for QRM (e.g. FMEA) that can be applied to different aspects of pharmaceutical quality.

Enablers of PQS…Enablers of PQS…

Page 25: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2525

Management Commitment Quality Policy Quality Planning Resource Management Internal Communication Management Review Control on Outsourcing/ Purchase Managing Change in Ownership

Management Management Responsibility…Responsibility…

Page 26: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2626

Continuous Improvement…Continuous Improvement…Of Process Performance and Product Quality Life Cycle Stage Goals:

Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuation

PQS Elements: Process performance and product quality monitoring system. Corrective action and preventive action (CAPA) system. Change management system Management review of process performance and product

quality.

Page 27: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2727

Of the Pharmaceutical Quality System Management Review of the Pharmaceutical Quality System. Monitoring of Internal and External Factors Impacting the

Pharmaceutical Quality System. Outcomes of Management Review and Monitoring

Continuous Improvement…Continuous Improvement…

Page 28: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2828

Pharmaceutical Manufacture…

             

USFDA’s Six Systems Model, An inspections approach.

Page 29: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

2929

Manufacturing Systems…Facilities & Equipment: Describes the methods for controlled premises, facility and

equipment.Laboratory Systems: Describes the methods for laboratory controls for starting

material, in-process/ finished products. Material Systems: Describes the methods for material controls, i.e. receipt,

handling, storage and dispensing. Packaging & Labeling Systems: Describes the methods for handling of finished products with

required packing & Labeling.Production Systems: Describes the methods for formula, process and practices during

production, by using the supporting systems.

Page 30: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3030

Quality System…

Quality is everyone’s responsibility, typically monitored by QA through…

Qualifications/ Validations In-Process Checks and Batch Release Documentation Control QMS tracking & Quality Metrics Training, Audits & Compliance

… ensure the state of control in 5 P’s of manufacturing systems.

Page 31: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3131

5 P’s and QA Controls…Premises (Includes Facility and Equipment)

Approval of Design and Qualifications/ Validations

Personnel Training and Qualifications

Procedures Approval, Distribution, Change controls and Training

Practices(Includes Process)

Training, BR checks, Validations and Audits

Products (Includes starting material, in-process and final product)

QC testing and control of other P’s (Premises, Personnel, Procedures and Practices)

Page 32: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3232

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 33: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3333

Definitions…

Validation: Establishing documented evidence, which provides a high degree of assurance, that a specific process will consistently produce a product meeting its pre-determined specifications and quality attributes.

Qualification: All the actions, with a documented evidence, that an equipment is designed and commissioned, and is consistently performing, to meet the intended requirements. The word validation is sometimes widened to incorporate the concept of qualification.

Process Validation: Process validation is establishing documented evidence, which provides a high degree of assurance, that a specific process will consistently produce a product meeting its pre-determined specifications and quality characteristics.

Page 34: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3434

Prospective Validation: Is the establishment of documented evidence, with high degree of assurance, that a process, procedure, system, equipment or mechanism used in manufacture does what it purports to do based on a pre-planned validation protocol.

Concurrent Validation: Establishment of documented evidence that a process does what it purports to do, based on information generated during actual implementation of the process.

Retrospective Validation: A process for a product which has been marketed based upon accumulated manufacturing, testing and control batch data.

Definitions…

Page 35: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3535

As per the Guidance for Industry by USFDA “Process Validation: General Principles and Practices”, effective from January 2011 …

Process Qualification: Conforming that the manufacturing process as designed is capable of reproducible commercial manufacturing.

Process Validation: The collection and evaluation of data, from the process design stage through commercial production, which establishes scientific evidence that a process is capable of consistently delivering quality products.

This certainly challenge our philosophy & practices, wrt qualifications/ validations, we have adopted as on date!

Definitions…

Page 36: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3636

New Approach…This approach is based on the understanding that, Quality, Safety and Efficacy are designed or built into the

product. Quality cannot be adequately assured merely by in-process

and finished product inspection or testing.

This approach describes Process Validation (PV) activities in three stages; Process Design Process Qualification Continued Process Verification

Page 37: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3737

PV Stages…Process Design: Building and Capturing Process Knowledge and Understanding. Establishing a strategy for process control (CPPs & CQAs). Process Qualification: Design of a Facility and Qualification of Utility and Equipment Process Performance Qualification. Continued Process Verification: Trend Analysis & Quality Metrics Review of Key Performance Indicators (KPIs).

All regulatory agencies expects that, the principles of Quality Risk Management (QRM) are integrated into qualifications/ validations.

Page 38: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3838

Validation Master Plan ( VMP)

Impact Assessment

Qualification

Design Qualification (DQ)

Installation Qualification (IQ)

User Requirement Specifications (URS)

Operational Qualification (OQ)

Performance Qualification (PQ)

Final Qualification Report

Validation

Analytical Method Validation (AMV)

Cleaning Validation (CV)

Process Validation (PV)

Final Validation Report

Monitoring/ Maintenance/ Calibration

Re-Qualification

Change Control

VALIDATION LIFE CYCLE

Factory Acceptance Test (FAT)

Page 39: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

3939

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 40: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4040

Definitions…Risk: The combination of probability of the harm and the severity of that harm.

Risk Assessment: A systematic process of organizing information to support a risk decision to be made within a risk management process. It consists of the identification of hazards and the analysis and evaluation of risks associated with exposure to those hazards.

Quality Risk Management (QRM): A systematic process for the assessment, control, communication and review of risks to the quality of the drug (medicinal) product across the product lifecycle.

Reference: ICH Q9 – Quality Risk Management (QRM); Harmonised Tripartite Guideline .

Page 41: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4141

Typical QRM Process

Page 42: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4242

Approach for QRM…

The manufacturing and use of a drug product, including its components, necessarily entail some degree of risk.

The risk to its quality, in the entire product life cycle, is just one component of the overall risk. The protection of patient by managing the risk to product quality, during it’s manufacture and/ or distribution, should be considered as prime importance by all the stake holders.

QRM is a systematic process designed to coordinate, facilitate and improve science-based decision making with respect to risk.

Page 43: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4343

Approach for QRM…The success of this exercise depends on the involvement of representatives, with the working knowledge of various important areas of product life cycle (e.g. Logistics, Engineering, Manufacturing, QA, QC and RA).

A practical approach for QRM is to define the scope for each risk assessment exercise, and conduct training to concerned personnel, where the representatives are able to identify and make informed judgments on threats to the individual process steps.

The selection and implementation of improvements then be assigned to individuals and shall be reviewed for effectiveness, post implementation.

Page 44: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4444

Risk Assessment…QRM begins with a well defined problem description or risk in question. Based on the problem/ risk, we shall constitute a team of experts from user and applicable cross functions, to execute the QRM process.

When the risk in question is well defined, appropriate risk management tool and the types of information needed to address the risk in question will be more readily identifiable.

As an aid to clearly defining the risk(s) for risk assessment purposes, three fundamental questions are often helpful: What might go wrong? What is the likelihood (probability) it will go wrong? What are the consequences (severity)?

Page 45: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4545

Risk Assessment…

Raw Material & Packing Material Suppliers

Warehouse of Manufacturing Plant

Ro

ad

, S

ea

, A

ir

Dispensing

Equipment/ Component Cleaning and Sterilization

Production and Packaging

Storage and Distribution

Ro

ad

, S

ea

, A

ir

Distributor/ Customer

Page 46: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4646

Risk Assessment…The QRM team shall carry out detailed process mapping of the activity, under scope of risk assessment. Particular attention shall be paid to interfaces along the product life cycle.

In the above process map, every entry and every arrow represents a risk points at which product threat could occur. Each process can be mapped separately and QRM can be effectively applied to all the stages of pharmaceutical manufacture.

All the risk areas and product sensitivities, i.e. customer complaints, deviations etc., and all the attributes related to facilities, equipment, personnel, environment, materials and practices/ procedures are considered for identifying the threats which could impact product quality and/ or safety.

Page 47: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4747

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 48: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4848

Deviation:Departure from an approved procedure, process and/ or established standard. This can be an unexpected/ planned event in non-compliance with established standard, system and/ or procedure, at any stage of manufacturing/ its associated activities.

Correction:Action refers to repair, rework and/ or adjustment and relates to the disposition of an existing non-conformity.

Corrective Action:Action taken to eliminate the causes of an existing non-conformity, defect or other undesirable situation in order to prevent re occurrence.

Preventive Action:Action taken to eliminate the cause of a potential non-conformity, defect or other undesirable situation in order to prevent re occurrence.

Definitions…

Page 49: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

4949

Terms in Industry… Deviation

Planned Deviation Un Planned Deviation

Out of Specification (OOS) Out of Limit (OOL) Out of Trend (OOT) Aberration Exception Un Usual Occurrence Incident

Something, which is a discrepancy/ abnormal, from the set standard and/ or routine occurrence.

Page 50: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5050

Reporting & Tracking of all the events in defined quality system framework.

Root cause investigation for all the failures/ non-conformances, with adequate impact assessment and CAPA.

Escalation mechanism and management responsibility/ involvement on handling these failures/ non-conformances.

Inspectors really look how well you handle any problems.

Hence, reviewing atypical event (deviations/OOS/ OOL/ OOT) reveals, just how well the quality system is working! (Ref. FDA News on PAIs).

Regulatory Perspective…

Page 51: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5151

Top 10 FDA 483 Items

*PAPC – Production and Process Controls

Source: QSIT – Presentation on CAPA during the workshop.

Regulatory Perspective…

Page 52: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5252

Identify all the unexpected/ atypical events in GMP areas. Acknowledge them as real deviations or whatever!. Thorough investigation to identify the root cause. Evaluate the impact, i.e. quality, regulatory, systemic and

business.

Identify the CAPAs, including responsibilities and time lines.

Decision on disposition of the batch and/ or move forward with routine operations.

Documenting all the events concurrently in a traceable manner.

Purpose of Notification…

Page 53: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5353

Challenge…The biggest challenge in any Quality System of the organization with respective to Deviations is…

Communication processes that are untimely, inefficient and lacking in ownership lead to identifying the True Root Cause and applying effective Corrective And Preventive Actions (CAPA).

Effective investigations for all atypical events, with adequate CAPAs, is an ultimate tool for any organization to comply with “Current” requirements of “GMPs”, which ensures continuous improvement.

Page 54: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5454

Is the most basic reason, which if eliminated, would Prevent Recurrence.

An identified reason for the presence of a defect or problem and/ or the source or origin of an event.

The goal of every deviation investigation is to identify the True Root Cause. This is critical to ensure that the most effective Corrective Action / Preventative Action is implemented.

Root Cause must be;Stated clearly and conciselyIs scientifically valid – the conclusion is based on the data and/or sound scientific

knowledge and principles.Stated with a level of confidence that is appropriate

True Root Cause…

Page 55: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5555

•In practice, the process is rarely sequential

• Not uncommon to go back to Generate Description after some level of problem analysis

• As significant new information becomes available, evaluate need to revise or update problem definition

At each stage, ask if the problem definition is still correct and complete

Define

Generate Description – Map the process, Brainstorm for causes, Identify what’s changed, organize information

Problem analysis and trouble-shooting

Test hypothesis

Drill down to the true root cause; Tools!

Evaluate after implementation

Product Impact

Problem Solving…

Page 56: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5656

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 57: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5757

Flow charts, Check sheets, process mapping Statistical tools, i.e. control charts, histograms, Pareto

charts etc., 5 – Whys Technique Cause and Effect Diagrams (Ishikawa diagram or

fish bone diagram). Failure Mode Effects analysis (FMEA) Failure Mode, Effects and Criticality Analysis (FMECA) Fault Tree Analysis (FTA) Hazard Analysis and Critical Control Points (HACCP) Hazard Operability analysis (HAZOP) Preliminary Hazard analysis (PHA)

The Tools…

Page 58: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5858

Developed at Toyota and is critical component of the problem solving training in it’s production system.

Method of asking questions to determine the true root cause of the problem and has potential to uncover underlying design, procedure or organization issues.

Provides a structured and layered approach to go from the effect to the first cause.

Why 5? Not a magic number Rule of thumb! Based on experience, 5 questions are

believed to be sufficient to get to the true root cause

5 Why? Technique…

Page 59: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

5959

Example (Deviation Event Information): During the first lot after shut-down, the temperature of the product in the holding tank exceeded the allowable 2 to 8 C range, triggering an alarm.

Operators found that the ball-valve controlling glycol flow to the tank jacket was in the closed position.

Valve was opened and the temperature returned to normal.

Cause:Temperature excursion due to closed glycol valve.

5 Why? Technique…

Page 60: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6060

Cause Effect Analysis…

Page 61: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6161

Cause Effect Analysis…

Page 62: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6262

Cause Effect Analysis…

Page 63: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6363

FMEA…

Page 64: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6464

FMEA…

Page 65: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6565

FMEA…

Page 66: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6666

FMEA…

Page 67: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6767

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 68: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6868

Case Study…Group A:

Group B:

Group C:

Page 69: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

6969

Agenda…

Basics of GMP Pharmaceutical Quality systems Qualifications/ Validations Quality Risk Management (QRM) Corrective & Preventive Actions (CAPA) RA/ Investigation Tools Case Study Moving Forward

Page 70: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

7070

Driving Force…

The driving force for implementation of a robust pharmaceutical quality system, to meet the CGMPs, is an effective “Documentation System”.

These documents are important…

To convey the commitments To define/ Implement systems and procedures For Reference during the operation Are legal and can be requested/ subpoenaed by a court of law. Can be used to prove GMP compliance.

…be sensitive towards them!

Page 71: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

7171

Take Away…Refer to written instructions and Never Assume!

Understand your own processes and improve “out of box” thinking abilities.

Data collection should always accompanied with data analysis to make scientifically justified decisions.

Notifications are appropriate tools and enable us to comply with CGMPs. Do not scare of them!

Qualification/ Validation of every thing we do/ adopt.

Risk Assessment and CAPAs should be your daily mantras!

Page 72: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

7272

GMPs will only work with the cooperation and understanding of the most important element and that is …

Critical Element…

…YOU

Page 73: BTM Workshop_QA jul 11

Business Time Managers Workshop at Unit IV; Jul./ Aug. 2011

7373

THANK YOU